50M+ people
in US + EU-4/UK with Severe Obesity & Diabetes/Prediabetes
need more than drugs
but less than surgery
ForePass Bridges The Gap: Unlocking Surgery-Level Weight Loss And Metabolic Reversal Potential
ForePass® is a fully reversible, perforation-free approach that overcomes the limitations of surgery and drugs—tailored for Class II & III patients (BMI ≥35) with comorbidities like type 2 diabetes, NASH, insulin resistance, or liver fibrosis
Keyron’s ForePass ® reproduces key mechanisms of
Metabolic surgery without requiring any incision
What we do
How it works
The final ForePass ® GD device may differ in size and characteristics to that shown in these representations.
Created with Safety
& Efficacy in mind
ForePass ® aims to reproduce:
- The safety of gastric balloons
- The efficacy of gastric bypass surgery
A team of
World Class Experts
Our team brings together world-renowned experts in diabesity, endoscopy, metabolic surgery and medical device engineering, alongside proven business leaders with outstanding track records in obesity and medical devices.
Redefining the
Standard of Care
Engineered for metabolic impact
ForePass® was developed by an experienced U.S. engineering team to combine endoscopic delivery with targeted metabolic mechanisms.
Compelling preclinical evidence
Preclinical studies demonstrated improvements in obesity, insulin resistance and metabolic disease, with favorable preclinical safety findings in swine
World-renowned multidisciplinary team
Leading experts in diabesity, endoscopy, metabolic surgery and medical device engineering, alongside proven industry executives.